Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US

 Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US

Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US

Shots:

  • Qiagen reports the launch of the Access Anti-SARS-CoV-2 Total test that runs on a portable device and provides accurate results on Total Ig Abs (IgA, IgM, IgG) in 10mins. The device can process up to 8 samples simultaneously or up to 32 tests/hour
  • The test was developed in collaboration with Ellume, following the US FDA’s EUA submission. The companies plan to launch it in the US in Aug’2020 while anticipates the CE-IVD marking in the EU with the initiation of commercialization in other markets in coming weeks
  • The test is performed on eHub & eStick system provides rapid qualitative serological in-vitro detection of total antibodies to SARS-CoV-2 in plasma & serum and has demonstrated 100% sensitivity & specificity

Click here ­to­ read full press release/ article | Ref: Qiagen | Image: Fierce Biotech

Related News: Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post